COVID-19 Vaccine: AIIMS Delhi Starts Screening Of Children For Covaxin Trials

COVID-19 Vaccine: AIIMS Delhi Starts Screening Of Children For Covaxin Trials

The three COVID-19 vaccines currently available in India – Covishield, Covaxin and Sputnik V – have not yet been approved for use among children
Coronavirus Outbreak, Coronavirus Vaccine, News
- in Coronavirus Outbreak, Coronavirus Vaccine, News
0
COVID-19 Vaccine: AIIMS Delhi Starts Screening Of Children For Covaxin TrialsIndia's drug regulator had granted permission for conducting the phase 2/3 clinical trial of Covaxin in the age group 2 to 18 years on May 12
Highlights
  • The Covaxin trial on children has already started at AIIMS Patna
  • Zydus Cadila's COVID vaccine is also being tested in children: Dr VK Paul
  • A national expert group formed to review COVID-19 infections in children

New Delhi: The screening of children for trial of Covaxin, India’s first indigenously developed COVID-19 vaccine, among those aged between 2 and 18 started at the AIIMS here on Monday (June 7). The trial on children has already started at AIIMS Patna to see if the Bharat Biotech jab is suitable for children. Participants would be given the vaccine after their screening report comes. The trial is to be conducted on 525 healthy volunteers. In the trial, the vaccine will be given by intramuscular route in two doses at day 0 and day 28.

The screening of children for conducting trial of Covaxin has started. Participants would be given the vaccine after their screening reports come, Dr Sanjay Rai, Professor at the Centre for Community Medicine at AIIMS, said.

Also Read: Pfizer Far Less Effective For Delta Variant Than Earlier Coronavirus Strains: Lancet Study

India’s drug regulator had granted permission for conducting the phase 2/3 clinical trial of Covaxin in the age group 2 to 18 years on May 12. Covaxin is being used on adults in India’s ongoing COVID-19 vaccination drive.

The government last week cautioned that even though COVID-19 has not taken a serious shape among children till now, its impact can increase among them if there is a change in virus behaviour or epidemiology dynamics, and said preparations are being strengthened to deal with any such situation.

Also Read: B.1.617 Variant Of SARS-CoV2 Drove Surge In The COVID-19 Cases In Last 2 Months

A national expert group has been formed to review COVID-19 infections in children and approach the pandemic in a renewed way to strengthen the nation’s preparedness, NITI Aayog Member (Health) V K Paul had said at a press conference. The group has examined signs which were not available four-five months before, he said. It has also considered available data, clinical profile, the country’s experience, disease dynamics, nature of the virus and the pandemic and has come up with guidelines, which will be publicly released soon.

While we have been systematically reviewing scientific developments in this area, the group has been formed to take an updated view of the situation, Dr Paul said.

Also Read: COVID-19: UK Regulator Approves Pfizer/Biontech Vaccine For 12-15-Year-Olds

Asked if the Pfizer vaccine, if it comes to India, will it be considered for children between the age of 12 and 15 years as being approved by the UK, Dr Paul had said that the country has its own vaccines which are being readied for children.

Child cohort is not a small cohort. My rough guess is that if it is between 12 to 18 years, this itself is about 13 to 14 crore population and for which we will need about 25-26 crore doses. We cannot have some people getting and others not getting. So we will have to take this into account when we strategise and make a decision based on how many doses of which vaccines are available, he said.

He further shared that Zydus Cadila’s vaccine is already being tested in children.

So when Zydus comes for licensure, hopefully in the next two weeks, may be we have enough data to take a view on whether the vaccine can be given to children, he said.

Watch: COVID-19 In Children: How Big A Threat Is ‘MIS-C’ And What Are Its Symptoms?

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)

NDTV – Dettol Banega Swasth India campaign is an extension of the five-year-old Banega Swachh India initiative helmed by Campaign Ambassador Amitabh Bachchan. It aims to spread awareness about critical health issues facing the country. In wake of the current COVID-19 pandemic, the need for WASH (WaterSanitation and Hygiene) is reaffirmed as handwashing is one of the ways to prevent Coronavirus infection and other diseases. The campaign highlights the importance of nutrition and healthcare for women and children to prevent maternal and child mortality, fight malnutrition, stunting, wasting, anaemia and disease prevention through vaccines. Importance of programmes like Public Distribution System (PDS), Mid-day Meal Scheme, POSHAN Abhiyan and the role of Aganwadis and ASHA workers are also covered. Only a Swachh or clean India where toilets are used and open defecation free (ODF) status achieved as part of the Swachh Bharat Abhiyan launched by Prime Minister Narendra Modi in 2014, can eradicate diseases like diahorrea and become a Swasth or healthy India. The campaign will continue to cover issues like air pollutionwaste managementplastic banmanual scavenging and sanitation workers and menstrual hygiene

World

19,66,15,634Cases
6,33,31,644Active
12,90,85,240Recovered
41,98,750Deaths
Coronavirus has spread to 194 countries. The total confirmed cases worldwide are 19,66,15,634 and 41,98,750 have died; 6,33,31,644 are active cases and 12,90,85,240 have recovered as on July 30, 2021 at 4:07 am.

India

3,15,72,344 44,230Cases
4,05,155 1,315Active
3,07,43,972 42,360Recovered
4,23,217 555Deaths
In India, there are 3,15,72,344 confirmed cases including 4,23,217 deaths. The number of active cases is 4,05,155 and 3,07,43,972 have recovered as on July 30, 2021 at 2:30 am.

State Details

State Cases Active Recovered Deaths
Maharashtra

62,90,156 7,242

81,933 3,980

60,75,888 11,032

1,32,335 190

Kerala

33,49,365 22,064

1,55,327 5,287

31,77,453 16,649

16,585 128

Karnataka

29,01,247 2,052

23,277 685

28,41,479 1,332

36,491 35

Tamil Nadu

25,55,664 1,859

21,207 314

25,00,434 2,145

34,023 28

Andhra Pradesh

19,62,049 2,107

21,279 280

19,27,438 1,807

13,332 20

Uttar Pradesh

17,08,373 60

784 16

16,84,834 44

22,755

West Bengal

15,26,539 766

11,300 70

14,97,116 822

18,123 14

Delhi

14,36,144 51

554 19

14,10,541 70

25,049

Chhattisgarh

10,01,781 130

2,086 140

9,86,175 270

13,520

Odisha

9,74,132 1,615

15,276 489

9,53,088 2,039

5,768 65

Rajasthan

9,53,622 17

259 9

9,44,410 26

8,953

Gujarat

8,24,829 27

268 6

8,14,485 33

10,076

Madhya Pradesh

7,91,796 18

130 0

7,81,153 18

10,513

Haryana

7,69,858 30

712 10

7,59,516 17

9,630 3

Bihar

7,24,719 46

481 1

7,14,596 42

9,642 3

Telangana

6,43,716 623

9,188 126

6,30,732 746

3,796 3

Punjab

5,99,005 58

553 6

5,82,162 60

16,290 4

Assam

5,64,030 1,299

14,114 385

5,44,695 1,664

5,221 20

Jharkhand

3,47,105 56

259 22

3,41,720 34

5,126

Uttarakhand

3,41,982 48

669 3

3,33,952 51

7,361

Jammu And Kashmir

3,21,207 181

1,144 5

3,15,686 175

4,377 1

Himachal Pradesh

2,05,728 229

1,098 145

2,01,110 84

3,520

Goa

1,70,900 90

1,077 5

1,66,679 93

3,144 2

Puducherry

1,20,725 98

972 49

1,17,961 49

1,792

Manipur

96,824 1,000

10,895 27

84,408 1,016

1,521 11

Tripura

78,059 271

3,640 221

73,665 488

754 4

Meghalaya

63,745 731

5,750 294

56,933 423

1,062 14

Chandigarh

61,948 5

37 1

61,102 4

809

Arunachal Pradesh

47,477 335

4,252 49

43,000 383

225 1

Mizoram

37,171 764

11,862 252

25,168 511

141 1

Nagaland

27,653 67

1,299 51

25,798 114

556 4

Sikkim

26,132 276

3,297 180

22,498 92

337 4

Ladakh

20,324 4

60 4

20,057 8

207

Dadra And Nagar Haveli

10,643 1

36 5

10,603 6

4

Lakshadweep

10,162 7

70 6

10,042 13

50

Andaman And Nicobar Islands

7,534 3

10 3

7,395

129

Coronavirus Outbreak: Full CoverageTesting CentresFAQs

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like

Delta Variant Of COVID-19 May Spread As Easily As Chickenpox, Cause More Severe Infection: Reports

COVID-19 Delta Variant: The document from the Centers for Disease Control and Prevention (CDC) outlines unpublished data that shows fully vaccinated people might spread the Delta variant, first identified in India, at the same rate as unvaccinated people, reports said